Skip to content

Computer-Assisted Cognitive Remediation in Schizophrenia: Individualized versus generic exercise plan

Computer-Assisted Cognitive Remediation in Schizophrenia: Individualized versus generic exercise plan - Cognitive Remediation

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
DRKS
Registry ID
DRKS00021628
Enrollment
60
Registered
2020-05-11
Start date
2012-10-10
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F20

Interventions

Group 1: Individualized Exercise Plan: focus on the three most impaired cognitive functions of the schizophrenic patients (n = 20) Group 2: Generic Exercise Plan: target the same set of six cognitive

Sponsors

Abteilung für Psychiatrie und Psychotherapie SRH Klinikum Karlsbad-Langensteinbach
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: (1) Patients should meet DSM-IV criteria for schizophrenia (295.1-295.3; 295.6; 295.9) confirmed with the MINI (2) Age between 18 and 55 years (3) IQ> 80 according to the Mehrfachwahl-Wortschatztest (4) No current substance abuse (standard drug screening in urine) (5) No documented or suspected major brain damage or other neurological diseases (e.g. stroke, epilepsy, concussion) (6) Patients must be clinically stable and able to provide informed consent

Exclusion criteria

Exclusion criteria: (1) Patients with Positive and Negative Syndrome Scale scores = 5 for any positive symptom item will be excluded to avoid confounding with acute psychotic symptoms (2) Patients with Hamilton Rating Scale for Depression scores = 20 will be excluded to avoid confounding with severe depressive symptoms (3) Cognitive deficits: in at least three domains scores below PR<16 (WAFA, WAFG, WAFS, NBV, ToL, Go/NoGo)

Design outcomes

Primary

MeasureTime frame
Neuropsychological performance, psychopathology and functional outcome were assessed at baseline and post-treatment. Psychopathology und demographics: PANSS, HAMD, M.I.N.I-SKID (only baseline), BDI, MWT-B (only baseline) Functional outcome: GAF, MINI-ICF-APP, SLOF Neuropsychological performance: alertness, divided attention, selective attention, working memory, planning, response inhibition

Countries

Germany

Contacts

Public ContactMatthias Weisbrod

Abteilung für Psychiatrie und Psychotherapie SRH Klinikum Karlsbad-Langensteinbach

Matthias.Weisbrod@srh.de01202613342

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026